Jacob Freedman

Papers

Total Citations

H-Index

About

Jacob Freedman is a leading figure in the field of interventional oncology, with a focused expertise in the precision treatment of liver malignancies. His research centers on advancing minimally invasive thermal ablation techniques, specifically through the integration of stereotactic navigation and robotic assistance. Dr. Freedman’s major contribution lies in systematically evaluating and quantifying the impact of these technologies on procedural accuracy and patient outcomes. His landmark 2021 systematic review and meta-analysis, which has garnered 44 citations, provides critical evidence that stereotactic navigation enhances treatment precision and safety for malignant liver tumors. This work serves as a foundational reference for clinicians seeking to optimize ablation protocols, demonstrating reduced complication rates and improved tumor targeting. By synthesizing a growing body of literature, Dr. Freedman has helped bridge the gap between emerging robotic systems and routine clinical practice. His research not only validates the efficacy of these advanced tools but also highlights the potential for broader adoption in oncologic surgery, positioning him as a key voice in the evolution of image-guided, minimally invasive cancer care.